That is looking very likely, but the spodumene market might see a slight improvement in 2020. Depends on which analyst you believe. Anyway, I'm giving them at least two more quarters to see if they can reduce costs, if not I will drop PLS from my portfolio. It is looking increasingly likely that the company will fail and the Chinese/CATL will take the asset.
Death Spiral, page-78
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.95 |
Change
0.060(2.08%) |
Mkt cap ! $8.883B | |||
| Open | High | Low | Value | Volume |
| $2.91 | $2.95 | $2.80 | $37.16M | 12.90M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 145182 | $2.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.95 | 119681 | 14 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PLS (ASX) Chart |